Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,494 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,594 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06543420 | The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery | unknown | N/A | 192 | Peking University First HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06543836 | ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer | unknown | Phase 2 | 68 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2024 |
| NCT06544577 | Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC | unknown | — | 350 | SciClone PharmaceuticalsINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06544668 | A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases | unknown | — | 3,500 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06545630 | Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases | unknown | Phase 1 | 10 | West China HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06546280 | A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation | unknown | Phase 2 | 38 | Zhujiang HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT03866499 | A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients | unknown | Phase 3 | 369 | Beta Pharma ShanghaiINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT04787289 | A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer | unknown | Phase 2 | 244 | British Columbia Cancer AgencyOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT04838327 | Rare Subtypes of Gastrointestinal Cancers | unknown | — | 130 | Aarhus University HospitalOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT05594927 | Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)(BESTPOP) | unknown | Phase 3 | 261 | Beijing Shenogen Biomedical Co., LtdINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT05749549 | Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers | unknown | Phase 1 / Phase 2 | 191 | Shanghai Blueray Biopharma Co., Ltd.INDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06494865 | " Role of Diffusion Weighted Image in the Diagnosis and Follow up of Breast Cancer" | unknown | — | 30 | Sohag UniversityOTHER | 0 | Aug 7, 2024 | clinicaltrials |
| NCT06496360 | Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer | unknown | — | 150 | Qilu Hospital of Shandong UniversityOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06540937 | Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor | unknown | Phase 2 | 50 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06541587 | Smart VR Mindfulness for Breast Cancer: Integrating Biofeedback and Evaluating Chemotherapy Effectiveness | unknown | N/A | 60 | Hsin Yi LuOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06541821 | Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients | unknown | — | 30 | Selcuk UniversityOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06543030 | Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular Carcinoma | unknown | — | 60 | Assiut UniversityOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT02991677 | Exercise Effect on Chemotherapy-Induced Neuropathic Pain | unknown | N/A | 60 | Baltimore VA Medical CenterFED | 1 | Aug 6, 2024 | clinicaltrials |
| NCT03631953 | Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas(ALTREM) | unknown | Phase 1 | 25 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT04636008 | Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer | unknown | Phase 1 / Phase 2 | 20 | West China HospitalOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT04716257 | A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients(proOMCRC) | unknown | — | 400 | West China HospitalOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06170021 | Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy | unknown | — | 215 | Sun Yat-sen UniversityOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06214689 | IDH1 and OCT4 in High Grade Astrocytoma | unknown | — | 35 | Assiut UniversityOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06392581 | Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia Patients(ALL-IFI) | unknown | — | 150 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06498752 | MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer | unknown | Phase 2 | 102 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06536946 | B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers | unknown | — | 50 | Sohag UniversityOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06539559 | Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer | unknown | Phase 2 | 60 | Wang JiayuOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06539806 | Clinical Study Evaluating the Effect of Losartan | unknown | N/A | 90 | Tanta UniversityOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06540495 | Virtual Personalized Exercise Program for Lung Cancer Patients | unknown | N/A | 60 | Northwell HealthOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06540508 | Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma | unknown | — | 30 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT05931068 | Perioperative Energy Expenditure in Major Liver Resection(PRO-NRG) | unknown | — | 20 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT05963464 | RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)(RADIOSO) | unknown | — | 300 | European Institute of OncologyOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06335342 | Radiotherapy Treatments for Neoplasms in the Head and Neck Region | unknown | — | 4,050 | European Institute of OncologyOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06505278 | The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy | unknown | Phase 2 | 70 | Sun Yat-sen UniversityOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06536712 | Effects of Exosome Adminstration in Preventing Early Leakage in Rectal Cancer Patients Undergoing Low Anterior Resection | unknown | Phase 1 | 20 | Tehran University of Medical SciencesOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06536725 | Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis | unknown | — | 35 | Tianjin Medical University Second HospitalOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06536855 | Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda | unknown | Phase 4 | 100,000 | Rwanda Biomedical CentreOTHER | 0 | Aug 5, 2024 | clinicaltrials |
| NCT04220944 | Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. | unknown | Phase 1 | 45 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT04483284 | Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients | unknown | Phase 2 | 28 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT06468267 | RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL. | unknown | Phase 2 | 50 | Xianmin Song, MDOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT06509945 | Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL | unknown | N/A | 50 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT06531850 | Prospective Study of Serum Marker LncRNA RP5-977B1 in Pulmonary Nodules | unknown | — | 200 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT06533709 | Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data | unknown | — | 146 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT00899223 | Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes | unknown | — | 1,500 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT04007185 | Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)(SIND) | unknown | — | 52 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT04149613 | Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer | unknown | — | 100 | American University of Beirut Medical CenterOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT04454476 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | unknown | Phase 1 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05190653 | Early Integration of Palliative and Supportive Care in Cellular Therapy(PALS_CT) | unknown | N/A | 152 | Alberta Health Services, CalgaryOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05214612 | Predictors and Prognostic Factors of Myasthenia Gravis Outcome | unknown | — | 30 | Assiut UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05412589 | mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC | unknown | Phase 2 | 35 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 9, 2024source: clinicaltrials